Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
1,006.65
732.04
842.28
985.39
895.76
792.88
795.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,006.65
732.04
842.28
985.39
895.76
792.88
795.18
Raw Material Cost
237.15
165.52
247.06
241.56
228.59
257.14
225.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.51
0.00
0.10
0.25
0.14
0.00
0.26
Selling and Distribution Expenses
511.37
408.01
404.31
486.55
446.99
397.68
395.60
Other Expenses
2.23
5.32
2.34
2.40
1.77
3.95
1.92
Total Expenditure (Excl Depreciation)
771.32
626.73
674.83
752.39
693.45
694.32
640.15
Operating Profit (PBDIT) excl Other Income
235.3
105.3
167.5
233
202.3
98.6
155
Other Income
19.25
53.68
19.88
27.19
17.93
19.38
18.78
Operating Profit (PBDIT)
254.58
177.96
207.36
278.77
239.29
136.18
194.72
Interest
0.51
0.00
0.10
0.25
0.14
0.00
0.26
Exceptional Items
-0.38
3.64
-1.34
-3.04
0.73
0.06
0.02
Gross Profit (PBDT)
769.50
566.52
595.23
743.82
667.17
535.74
570.10
Depreciation
0.00
19.06
19.96
19.06
19.06
20.91
20.91
Profit Before Tax
253.70
162.53
185.97
256.42
220.82
115.33
173.57
Tax
36.94
13.79
25.22
35.49
30.49
13.24
24.26
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
216.82
148.68
160.84
222.65
190.38
101.93
149.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
216.82
148.68
160.84
222.65
190.38
101.93
149.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.08
-0.00
-0.05
0.13
-0.05
0.00
-0.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
216.73
148.68
160.79
222.79
190.33
101.93
149.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,311.52
3,072.53
2,893.84
2,703.21
2,934.07
2,791.04
2,711.12
Earnings per share (EPS)
0.39
0.26
0.28
0.39
0.34
0.18
0.27
Diluted Earnings per share
0.39
0.26
0.28
0.39
0.34
0.18
0.27
Operating Profit Margin (Excl OI)
23.38%
14.37%
19.89%
23.6%
22.58%
12.09%
19.5%
Gross Profit Margin
25.2%
24.81%
24.45%
27.96%
26.78%
17.18%
24.46%
PAT Margin
21.54%
20.31%
19.1%
22.6%
21.25%
12.86%
18.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2025 is 12.38% vs 15.19% in Mar 2024
Consolidate Net Profit
YoY Growth in quarter ended Mar 2025 is 13.87% vs 31.97% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2025 is 6.28% vs 24.45% in Mar 2024
Interest
YoY Growth in quarter ended Mar 2025 is 400.00% vs -95.83% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
Compare Quarterly Results Of Henan Lingrui Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,006.65
0
1,006.65
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,006.65
0
1,006.65
Raw Material Cost
237.15
0
237.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.51
0
0.51
Selling and Distribution Expenses
511.37
0
511.37
Other Expenses
2.23
0.00
2.23
Total Expenditure (Excl Depreciation)
771.32
0
771.32
Operating Profit (PBDIT) excl Other Income
235.33
0.00
235.33
Other Income
19.25
0
19.25
Operating Profit (PBDIT)
254.58
0
254.58
Interest
0.51
0
0.51
Exceptional Items
-0.38
0
-0.38
Gross Profit (PBDT)
769.50
0
769.50
Depreciation
0.00
0
0.00
Profit Before Tax
253.70
0
253.70
Tax
36.94
0
36.94
Provisions and contingencies
0
0
0.00
Profit After Tax
216.82
0
216.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
216.82
0
216.82
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.08
0
-0.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
216.73
0
216.73
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,311.52
0
3,311.52
Earnings per share (EPS)
0.39
0
0.39
Diluted Earnings per share
0.39
0
0.39
Operating Profit Margin (Excl OI)
23.38%
0%
0.00
23.38%
Gross Profit Margin
25.20%
0%
0.00
25.20%
PAT Margin
21.54%
0%
0.00
21.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 100.67 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 37.53% vs -13.10% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 12.38% vs 15.19% in Mar 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 21.67 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 45.73% vs -7.52% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 13.87% vs 31.97% in Mar 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.53 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 89.30% vs -33.71% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 6.28% vs 24.45% in Mar 2024
Quarterly - Interest
Interest 0.05 Million
in Mar 2025Figures in Million
QoQ Growth in quarter ended Mar 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 400.00% vs -95.83% in Mar 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.38%
in Mar 2025Figures in %
QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
